Bioventus Inc. BVS
At closeNov 13, 2026, 4:00 PM EST
After hours · Nov 13, 4:00 PM ET
- YTD
- +43.28%
- 1 year
- +40.82%
BVS free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
72,111,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 72,111,000 | 34,322,000 | 90.83% |
| FY 2024 | 2024-12-31 | 37,789,000 | 29,807,000 | 373.43% |
| FY 2023 | 2023-12-31 | 7,982,000 | 22,997,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -15,015,000 | -24,486,000 | -258.54% |
| FY 2021 | 2021-12-31 | 9,471,000 | -45,749,000 | -82.85% |
| FY 2020 | 2020-12-31 | 55,220,000 | 16,849,000 | 43.91% |
| FY 2019 | 2019-12-31 | 38,371,000 | -4,255,000 | -9.98% |
| FY 2018 | 2018-12-31 | 42,626,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:00:48.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.